Medical and procedural treatment of androgenetic alopecia - Where are we?

Nathalie Y Ly, Sophia Fruechte, Maria K Hordinsky, Neil Sadick, Suleima Arruda et al.

Review Journal of the American Academy of Dermatology 2023 20 اقتباسات

<\/script>\n

`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D37591565'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

Study Design

نوع الدراسة: Review
المجتمع المدروس: Patients with androgenetic alopecia

التدخل: Medical and procedural treatment of androgenetic alopecia - Where are we? LDOM, finasteride, PRP, photobiomodulation
المقارن: None
النتيجة الأولية: AGA treatment advances overview
اتجاه التأثير: Positive
خطر التحيز: Unclear

Abstract

Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.